Unknown

Dataset Information

0

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.


ABSTRACT:

Purpose

Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) testing has traditionally been performed in patients with colorectal (CRC) and endometrial cancer (EC) to screen for Lynch syndrome (LS)-associated cancer predisposition. The recent success of immunotherapy in high-frequency MSI (MSI-H) and/or MMR-D tumors now supports testing for MSI in all advanced solid tumors. The extent to which LS accounts for MSI-H across heterogeneous tumor types is unknown. Here, we establish the prevalence of LS across solid tumors according to MSI status.

Methods

MSI status was determined using targeted next-generation sequencing, with tumors classified as MSI-H, MSI-indeterminate, or microsatellite-stable. Matched germline DNA was analyzed for mutations in LS-associated mismatch repair genes ( MLH1, MSH2, MSH6, PMS2, EPCAM). In patients with LS with MSI-H/I tumors, immunohistochemical staining for MMR-D was assessed.

Results

Among 15,045 unique patients (more than 50 cancer types), LS was identified in 16.3% (53 of 326), 1.9% (13 of 699), and 0.3% (37 of 14,020) of patients with MSI-H, MSI-indeterminate, and microsatellite-stable tumors, respectively ( P < .001). Among patients with LS with MSI-H/I tumors, 50% (33 of 66) had tumors other than CRC/EC, including urothelial, prostate, pancreas, adrenocortical, small bowel, sarcoma, mesothelioma, melanoma, gastric, and germ cell tumors. In these patients with non-CRC/EC tumors, 45% (15 of 33) did not meet LS genetic testing criteria on the basis of personal/family history. Immunohistochemical staining of LS-positive MSI-H/I tumors demonstrated MMR-D in 98.2% (56 of 57) of available cases.

Conclusion

MSI-H/MMR-D is predictive of LS across a much broader tumor spectrum than currently appreciated. Given implications for cancer surveillance and prevention measures in affected families, these data support germline genetic assessment for LS for patients with an MSI-H/MMR-D tumor, regardless of cancer type or family cancer history.

SUBMITTER: Latham A 

PROVIDER: S-EPMC6553803 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Latham Alicia A   Srinivasan Preethi P   Kemel Yelena Y   Shia Jinru J   Bandlamudi Chaitanya C   Mandelker Diana D   Middha Sumit S   Hechtman Jaclyn J   Zehir Ahmet A   Dubard-Gault Marianne M   Tran Christina C   Stewart Carolyn C   Sheehan Margaret M   Penson Alexander A   DeLair Deborah D   Yaeger Rona R   Vijai Joseph J   Mukherjee Semanti S   Galle Jesse J   Dickson Mark A MA   Janjigian Yelena Y   O'Reilly Eileen M EM   Segal Neil N   Saltz Leonard B LB   Reidy-Lagunes Diane D   Varghese Anna M AM   Bajorin Dean D   Carlo Maria I MI   Cadoo Karen K   Walsh Michael F MF   Weiser Martin M   Aguilar Julio Garcia JG   Klimstra David S DS   Diaz Luis A LA   Baselga Jose J   Zhang Liying L   Ladanyi Marc M   Hyman David M DM   Solit David B DB   Robson Mark E ME   Taylor Barry S BS   Offit Kenneth K   Berger Michael F MF   Stadler Zsofia K ZK  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20181030 4


<h4>Purpose</h4>Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) testing has traditionally been performed in patients with colorectal (CRC) and endometrial cancer (EC) to screen for Lynch syndrome (LS)-associated cancer predisposition. The recent success of immunotherapy in high-frequency MSI (MSI-H) and/or MMR-D tumors now supports testing for MSI in all advanced solid tumors. The extent to which LS accounts for MSI-H across heterogeneous tumor types is unknown. Here,  ...[more]

Similar Datasets

| S-EPMC11002576 | biostudies-literature
| S-EPMC10323896 | biostudies-literature
| S-EPMC10629437 | biostudies-literature
| S-EPMC2901607 | biostudies-literature
| S-EPMC6803663 | biostudies-literature
2023-06-01 | GSE211222 | GEO
| S-EPMC5444926 | biostudies-literature
| S-EPMC9367254 | biostudies-literature
| S-EPMC7028913 | biostudies-literature
| S-EPMC11861458 | biostudies-literature